Vitality Watch

Dossier pubmed review 30-may-2026
Narrative review or expert overview without new data

Cell senescence in chronic pain: An integrative perspective on cellular and neural mechanisms.

Key claim: Cellular senescence across pain-processing cell types may sustain chronic pain via SASP, mitochondrial dysfunction, and epigenetic alterations, and senolytics or SASP modulators are proposed as therapeutic strategies.

Abstract

Chronic pain is characterized by persistent neural sensitization, yet the cellular processes underlying its maintenance remain incompletely understood. Cell senescence, has recently emerged as a potential contributor to chronic pain. In this review, we summarize evidence of senescence across multiple cell types involved in pain processing and discuss how senescent cells influence neural function through mechanisms including the senescence-associated secretory phenotype (SASP), mitochondrial dysfunction, and epigenetic alterations. We further propose that cell senescence acts as a key link between cellular dysfunction and neural sensitization, forming a self-reinforcing network that sustains chronic pain. Importantly, targeting senescence-related pathways, including senolytics and modulators of SASP, may represent promising strategies for chronic pain therapies. This integrative perspective provides a framework for understanding chronic pain and highlights new directions for therapeutic intervention.

Why this matters

This review extends the senolytics/SASP-modulator thesis from canonical age-related organ pathologies into chronic pain, a high-prevalence indication with limited disease-modifying options. It reframes senescence-driven mitochondrial dysfunction, SASP, and epigenetic alterations across neurons, glia, and immune cells as a candidate substrate for pain chronicity — but the biology-to-clinic gap is large: no human trials yet test senolytics on pain endpoints, and the pitch outruns the direct evidence.

Source

Link

Briefing card

Cell senescence in chronic pain: An integrative perspective on cellular and neural mechanisms.
Stage: review · pubmed · 30-may-2026

Cellular senescence across pain-processing cell types may sustain chronic pain via SASP, mitochondrial dysfunction, and epigenetic alterations, and senolytics or SASP modulators are proposed as therapeutic strategies.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.neubiorev.2026.106789

build build 880 · 2bcef25 · 2026-11-18